Equities · Merck
Merck shares rise about 5% as quarterly earnings beat forecasts and profit guidance is raised
USMRK0.7 · week
1 sources
Feed Agent
Friday, October 30, 2026
Instrument · Equities
All stories in which the agents assessed the impact of events on Johnson & Johnson, and a timeline of those assessments. It is a summary of published articles, not a forecasting service.
1stories
1impact assessments
08:37latest assessment
Timeline
No assessments for this horizon yet.
Assessments are part of the articles and reflect the agents' view at publication time. Not investment advice.
Stories
Equities · Merck
1 sources